MOLM-16 Cells
USUSD$500.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | MOLM-16 is a human leukemia cell line derived from the peripheral blood of an adult woman with minimally differentiated acute myeloid leukemia (AML-M0) at relapse. This line exhibits a distinctive immunophenotype consistent with a myeloid/natural killer (NK) precursor leukemia, expressing CD7, CD13, CD33, CD34, and CD56. Additionally, it displays features of megakaryocytic differentiation, evidenced by the expression of markers such as CD41, CD61, CD36, CD62P, CD110, CD151, thrombospondin, von Willebrand factor (vWF), and fibrinogen. The presence of platelet peroxidase in the nuclear envelope, observed by electron microscopy, further confirms its megakaryoblastic lineage characteristics. MOLM-16 demonstrates cytokine-dependent growth and responds to a range of hematopoietic growth factors including erythropoietin (EPO), granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), PIXY321, and thrombopoietin (TPO). Cytogenetic analysis reveals complex karyotypic abnormalities such as t(6;8)(q21;q24.3) and t(9;18)(q13;q21), indicating genomic instability common in acute leukemia. The cell line lacks expression of T- and B-lymphoid markers, consistent with its myeloid/NK precursor profile, and is negative for myeloperoxidase (MPO) activity, a hallmark of AML-M0. Due to its unique combination of myeloid, NK, and megakaryocytic features, MOLM-16 serves as a valuable in vitro model for investigating the biology of minimally differentiated AML, megakaryopoiesis, and leukemic differentiation pathways. |
|---|---|
| 生物體 | Human |
| 組織 | Peripheral blood |
| 疾病 | Adult acute myeloid leukemia |
| 同義詞 | MOLM16 |
特徵
| 年齡 | 77 years |
|---|---|
| 性別 | Female |
| 族裔 | Japanese |
| 細胞類型 | Epithelial like |
| 生長特性 | Suspension |
監管數據
| 引用 | MOLM-16 (Cytion catalog number 305831) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_2120 |
生物分子資料
| 突變譜 | Mutation: TP53, Simple, p.Val173Met (c.517G>A), Heterozygous (Cosmic-CLP=1330948), TP53, Simple, p.Cys238Ser (c.713G>C), Heterozygous (Cosmic-CLP=1330948) |
|---|
處理方式
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS |
| 解離試劑 | Accutase |
| 倍增時間 | ca. 50-80 hours |
| 播種密度 | 1 to 3 x 104 cells/cm2 |
| 流體更新 | 2 to 3 times per week |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 305831-160326 | 分析證明書 | 04. May. 2026 | 305831 |